JULIA SCHNEIDER: Open Payments
NPI 1215156815 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 19 payments from 10 companies in 2025. Trend: 2023 $846 · 2024 $139 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 4 | $275 |
| Daiichi Sankyo Inc. | 4 | $187 |
| Merck Sharp & Dohme LLC | 2 | $128 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| ABBVIE INC. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Eisai Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| pharmaand GmbH | 1 | $19 |
Products named: Enhertu, Tivdak, KEYTRUDA, ELAHERE, LYNPARZA, Lenvima, Flexitouch Plus, VERZENIO.
Industry payments across NC — which companies pay providers there.
